Product Information
CLONAZEPAM 2 MG ODT is a generic product labeled by Par Health USA, LLC, priced at $0.8510 per EA under NDC 49884031002. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2 mg/1
Manufacturer
Par Health USA, LLCNDC
49884031002
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077171On Market Since
8/5/2005
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG ODT has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 20.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8510 per EA |
|---|---|
| All-time high | $1.3975 (Oct 10, 2018) |
| All-time low | $0.6478 (Jan 17, 2024) |
| 52-week high | $1.0328 |
| 52-week low | $0.8241 |
| Median price | $1.0537 |
| Average price | $1.0934 |
| Largest weekly change | +63.3% (Mar 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG ODT, manufactured by Par Health USA, LLC, is $0.8510 per EA (NDC 49884031002), effective Jun 24, 2026.
How has the price of CLONAZEPAM 2 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG ODT has declined 20.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG ODT?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 2 MG ODT has ranged from a low of $0.6478 (Jan 17, 2024) to a high of $1.3975 (Oct 10, 2018), with a median of $1.0537 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG ODT?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CLONAZEPAM 2 MG TABLET, is $0.0378 per EA — about 96% below CLONAZEPAM 2 MG ODT.
Who manufactures CLONAZEPAM 2 MG ODT?
CLONAZEPAM 2 MG ODT (NDC 49884031002) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification